A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| 4-Amiobutaraldehyde diethyl acetal | 4-Amiobutaraldehyde diethyl acetal. Group: Biochemicals. Alternative Names: 4,4-Diethoxybutylaminel. Grades: Highly Purified. CAS No. 6346-9-4. Pack Sizes: 5g, 10g, 25g, 50g, 100g. Molecular Formula: C8H19NO2. US Biological Life Sciences. |  Worldwide |
| 4A Molecular Sieve | 4A Molecular Sieve. Group: 4a molecular sieve. CAS No. 11113-61-4. Pack Sizes: 500g. |  |
| 4A-MPLA | 4A-MPLA, the synthetic antigen-adjuvant, is employed in vaccines that bolster immune responses to infectious agents and cancers. The toll-like receptor 4 (TLR4) is vigorously activated by this powerful agonist, which, when given with other adjuvants, augments vaccine effectiveness during vaccination programs intended to combat bacterial and viral infections, including tuberculosis, influenza, and meningitis. Synonyms: Monophosphoryl Tetra-acyl Lipid A. Grades: 98%. CAS No. 2260669-09-6. Molecular formula: C68H132N3O19P. Mole weight: 1326.76. |  |
| 4-Amylaniline | 4-Amylaniline. Group: Liquid crystal (lc) building blocksliquid crystal (lc) materials. Alternative Names: 4-Pentylaniline. CAS No. 33228-44-3. Product ID: 4-pentylaniline. Molecular formula: 163.26. Mole weight: C11H17N. CCCCCC1=CC=C(C=C1)N. InChI=1S / C11H17N / c1-2-3-4-5-10-6-8-11 (12) 9-7-10 / h6-9H, 2-5, 12H2, 1H3. DGFTWBUZRHAHTH-UHFFFAOYSA-N. >97.0%(GC)(T). | |
| 4-Amylbenzoic Acid | 4-Amylbenzoic Acid. Group: Liquid crystal (lc) building blocks. CAS No. 26311-45-5. Product ID: 4-pentylbenzoic acid. Molecular formula: 192.25g/mol. Mole weight: C12H16O2. CCCCCC1=CC=C(C=C1)C(=O)O. InChI=1S / C12H16O2 / c1-2-3-4-5-10-6-8-11 (9-7-10) 12 (13) 14 / h6-9H, 2-5H2, 1H3, (H, 13, 14). CWYNKKGQJYAHQG-UHFFFAOYSA-N. | |
| 4-Amyloxybenzaldehyde | 4-Amyloxybenzaldehyde. Group: Liquid crystal (lc) building blocks. CAS No. 5736-91-4. Product ID: 4-pentoxybenzaldehyde. Molecular formula: 192.25g/mol. Mole weight: C12H16O2. CCCCCOC1=CC=C(C=C1)C=O. InChI=1S / C12H16O2 / c1-2-3-4-9-14-12-7-5-11 (10-13) 6-8-12 / h5-8, 10H, 2-4, 9H2, 1H3. YAPVGSXODFOBBR-UHFFFAOYSA-N. | |
| 4-Amyloxybenzaldehyde, 98% | 4-Amyloxybenzaldehyde, 98%. Group: Liquid crystal (lc) materials. CAS No. 5736-91-4. Product ID: 4-pentoxybenzaldehyde. Molecular formula: 192.25g/mol. Mole weight: C12H16O2. CCCCCOC1=CC=C(C=C1)C=O. InChI=1S / C12H16O2 / c1-2-3-4-9-14-12-7-5-11 (10-13) 6-8-12 / h5-8, 10H, 2-4, 9H2, 1H3. YAPVGSXODFOBBR-UHFFFAOYSA-N. | |
| 4-Amyloxybenzoic Acid | 4-Amyloxybenzoic Acid. Group: Liquid crystal (lc) building blocksliquid crystal (lc) materials. CAS No. 15872-41-0. Product ID: 4-pentoxybenzoic acid. Molecular formula: 208.25g/mol. Mole weight: C12H16O3. CCCCCOC1=CC=C(C=C1)C(=O)O. InChI=1S / C12H16O3 / c1-2-3-4-9-15-11-7-5-10 (6-8-11) 12 (13) 14 / h5-8H, 2-4, 9H2, 1H3, (H, 13, 14). OZPPUPJQRJYTNY-UHFFFAOYSA-N. | |
| 4'-(Amyloxy)benzylidene-4-cyanoaniline | 4'-(Amyloxy)benzylidene-4-cyanoaniline. Group: Liquid crystal (lc) building blocksliquid crystal (lc) materials. Alternative Names: 4'-(Pentyloxy)benzylidene-4-cyanoaniline. CAS No. 37075-25-5. Product ID: 4-[ (4-pentoxyphenyl) methylideneamino]benzonitrile. Molecular formula: 292.38. Mole weight: C19H20N2O. CCCCCOC1=CC=C (C=C1)C=NC2=CC=C (C=C2)C#N. InChI=1S / C19H20N2O / c1-2-3-4-13-22-19-11-7-17 (8-12-19) 15-21-18-9-5-16 (14-20) 6-10-18 / h5-12, 15H, 2-4, 13H2, 1H3. IUWUDHSOMQRZCV-UHFFFAOYSA-N. 97%+. | |
| 4-Amylphenyl 4-methoyxbenzoate | 4-Amylphenyl 4-methoyxbenzoate. Group: Liquid crystal (lc) materials. Alternative Names: NEMATAL 105; 4-AMYLPHENYL 4-METHOYXBENZOATE; 4-METHOXYBENZOIC ACID-4-(N-PENTYL)PHENYL ESTER; 4-PENTYLPHENYL 4-METHOXYBENZOATE; 4-N-PENTYLPHENYL P-ANISATE; p-pentylphenyl p-anisate; 4-METHOXYBENZOIC ACID-4-(N-PENTYL)PHENOL ESTER; 4-n-Pentylphenylp-anisate,4-Amylp. CAS No. 38444-13-2. Product ID: (4-pentylphenyl) 4-methoxybenzoate. Molecular formula: 298.38. Mole weight: C19< / sub>H22< / sub>O3< / sub>. CCCCCC1=CC=C (C=C1)OC (=O)C2=CC=C (C=C2)OC. UISXVYOLBGBYCV-UHFFFAOYSA-N. 96%. | |
| 4-Amylpridine | 4-Amylpridine. Group: Biochemicals. Alternative Names: 4-Pentylpyridine. Grades: Highly Purified. CAS No. 2961-50-4. Pack Sizes: 1g, 2g, 5g, 10g, 25g. Molecular Formula: C10H15N. US Biological Life Sciences. | Worldwide |
| 4-Androsten-11 β-ol-3,17-dione | 4-Androsten-11 β-ol-3,17-dione. Group: Biochemicals. Alternative Names: (11 β)-11-Hydroxy-androst-4-ene-3,17-dione; 11 β-Hydroxy-androst-4-ene-3,17-dione; (11 β)-11-Hydroxyandrost-4-ene-3,17-dione; 11 β-Hydroxy-4-androsten-3,17-dione; 11 β-Hydroxy-Δ4-androstene-3,17-dione; 11 β-Hydroxyandrost-4-ene-3,17-dione; 4-Androstene-11 β-ol-3,17-dione; NSC 12167; NSC 17102; U 2826; Δ4-Androsten-11 β-ol-3,17-dione; Δ4-Androstene-11 β-ol-3,17-dione. Grades: Highly Purified. CAS No. 382-44-5. Pack Sizes: 100mg. Molecular Formula: C19H26O3, Molecular Weight: 302.41. US Biological Life Sciences. | Worldwide |
| 4-ANDROSTEN-17α-OL-3-ONE ACETATE | 4-ANDROSTEN-17α-OL-3-ONE ACETATE. Group: Biochemicals. Alternative Names: EPITESTOSTERONE ACETATE. US Biological Life Sciences. | Worldwide |
| 4-Androsten-17β-ol-3-one sulphate,sodium salt | 4-Androsten-17β-ol-3-one sulphate,sodium salt. Uses: Designed for use in research and industrial production. Product Category: Steroidal Compounds. CAS No. 651-45-6. Molecular formula: C19H27O5NaS. Mole weight: 390.47. Purity: 95%+. Product ID: ACM651456. Alfa Chemistry ISO 9001:2015 Certified. |  |
| 4-Androsten-17b-ol-3,6-dione | 4-Androsten-17b-ol-3,6-dione. Group: Biochemicals. Alternative Names: (17b)-17-Hydroxyandrost-4-ene-3,6-dione; 17b-Hydroxyandrost-4-ene-3,6-dione. Grades: Highly Purified. CAS No. 570-94-5. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C19H26O3. US Biological Life Sciences. | Worldwide |
| 4-Androsten-2α,17β-diol-3-one | 4-Androsten-2α,17β-diol-3-one. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 2-ALPHA-HYDROXYTESTOSTERONE;4-ANDROSTENE-2ALPHA,17BETA-DIOL-3-ONE;4-ANDROSTEN-2-ALPHA, 17-BETA-DIOL-3-ONE;2A hydroxytestosterone--dea schedule*iii item;2α-hydroxytestosterone;4-androstene-2α,17β-diol-3-one;2α,17β-Dihydroxyandrost-4-en-3-one. Product Category: Steroidal Compounds. CAS No. 4075-14-3. Molecular formula: C19H28O3. Mole weight: 304.42. Purity: 95%+. IUPACName: (2R,8R,9S,10R,13S,14S,17S)-2,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one. Canonical SMILES: CC12CCC3C(C1CCC2O)CCC4=CC(=O)C(CC34C)O. Density: 1.19g/cm³. Product ID: ACM4075143. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Androsten-2α-ol-3,17-dione | 4-Androsten-2α-ol-3,17-dione. Uses: Designed for use in research and industrial production. Product Category: Steroidal Compounds. CAS No. 571-17-5. Molecular formula: C19H26O3. Mole weight: 302.41. Purity: 95%+. Product ID: ACM571175. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Androsten-2β-ol-3,17-dione | 4-Androsten-2β-ol-3,17-dione. Uses: Designed for use in research and industrial production. Product Category: Steroidal Compounds. CAS No. 571-16-4. Molecular formula: C19H26O3. Mole weight: 302.41. Purity: 95%+. Product ID: ACM571164. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Androsten-3,16-dione | 4-Androsten-3,16-dione. Uses: Designed for use in research and industrial production. Product Category: Steroidal Compounds. CAS No. 571-52-8. Molecular formula: C19H26O2. Mole weight: 286.41. Purity: 95%+. Product ID: ACM571528. Alfa Chemistry ISO 9001:2015 Certified. Categories: 4-androsten-3,17-dione. | |
| 4-Androsten-3,17-dione 19-aldehyde | 4-Androsten-3,17-dione 19-aldehyde. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 19-ALDOANDROSTENEDIONE;4-ANDROSTEN-3,17-DIONE 19-ALDEHYDE;4-ANDROSTEN-19-AL-3,17-DIONE;4-ANDROSTEN-3,17,19-TRIONE;19-oxo-delta(4) androstene-3,17-dione;19-Oxoandrostenedione;3,17-Dioxoandrost-4-en-19-al;(8R,9S,10S,13S,14S)-13-methyl-3,17-dioxo-2,6,7,8,9. Product Category: Steroidal Compounds. CAS No. 968-49-0. Molecular formula: C19H24O3. Mole weight: 300.39. Purity: 95%+. IUPACName: (8R,9S,10S,13S,14S)-13-methyl-3,17-dioxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde. Canonical SMILES: CC12CCC3C(C1CCC2=O)CCC4=CC(=O)CCC34C=O. Density: 1.18g/cm³. Product ID: ACM968490. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Androsten-3,6,17-trione | 4-Androsten-3,6,17-trione. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4-ANDROSTEN-3,6,17-TRIONE;4-ANDROSTENE-3,6,17-TRIONE;ANDROST-4-ENE-3,6,17-TRIONE;4-Androstenetrione;4-Androstenetriol;(8R,9S,10R,13S,14S)-10,13-dimethyl-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,6,17-trione. Product Category: Steroidal Compounds. Appearance: Yellow Solid. CAS No. 2243-6-3. Molecular formula: C19H24O3. Mole weight: 300.39. Purity: 95%+. IUPACName: (8R,9S,10R,13S,14S)-10,13-dimethyl-1,2,7,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,6,17-trione. Canonical SMILES: CC12CCC3C(C1CCC2=O)CC(=O)C4=CC(=O)CCC34C. Density: 1.18. Product ID: ACM2243063. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Androsten-3α-ol-17-one | 4-Androsten-3α-ol-17-one. Uses: Designed for use in research and industrial production. Product Category: Steroidal Compounds. CAS No. 2791-99-3. Molecular formula: C19H28O2. Mole weight: 288.42. Purity: 95%+. Product ID: ACM2791993. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Androsten-3β,11β,17β-triol | 4-Androsten-3β,11β,17β-triol. Uses: Designed for use in research and industrial production. Product Category: Steroidal Compounds. CAS No. 15780-13-9. Molecular formula: C19H30O3. Mole weight: 306.44. Purity: 95%+. Product ID: ACM15780139. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Androsten-3β,17α-diol | 4-Androsten-3β,17α-diol. Uses: Designed for use in research and industrial production. Product Category: Steroidal Compounds. CAS No. 15216-04-3. Molecular formula: C19H30O2. Mole weight: 290.44. Purity: 95%+. Product ID: ACM15216043. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Androsten-3β,17β-diol-11-one | 4-Androsten-3β,17β-diol-11-one. Uses: Designed for use in research and industrial production. Product Category: Steroidal Compounds. CAS No. 14485-67-7. Molecular formula: C19H28O3. Mole weight: 304.42. Purity: 95%+. Product ID: ACM14485677. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Androsten-3β,17β-diol-11-one diacetate | 4-Androsten-3β,17β-diol-11-one diacetate. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4-ANDROSTEN-3-BETA, 17-BETA-DIOL-11-ONE DIACETATE. Product Category: Steroidal Compounds. CAS No. 4134-41-2. Molecular formula: C23H32O5. Mole weight: 388.5. Purity: 95%+. IUPACName: 4-ANDROSTEN-3-β, 17-β-DIOL-11-ONE DIACETATE. Product ID: ACM4134412. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Androsten-3β,6α,17β-triol | 4-Androsten-3β,6α,17β-triol. Uses: Designed for use in research and industrial production. Product Category: Steroidal Compounds. CAS No. 15780-14-0. Molecular formula: C19H30O3. Mole weight: 306.44. Purity: 95%+. Product ID: ACM15780140. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Androsten-3β,6β-diol-17-one | 4-Androsten-3β,6β-diol-17-one. Uses: Designed for use in research and industrial production. Product Category: Steroidal Compounds. CAS No. 60268-49-7. Molecular formula: C19H28O3. Mole weight: 304.42. Purity: 95%+. Product ID: ACM60268497. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Androsten-3-one | 4-Androsten-3-one. Uses: Designed for use in research and industrial production. Product Category: Steroidal Compounds. CAS No. 2872-90-4. Molecular formula: C19H28O. Mole weight: 272.43. Purity: 95%+. Product ID: ACM2872904. Alfa Chemistry ISO 9001:2015 Certified. Categories: Androst-4-en-3-one. | |
| 4-Androsten-4-chloro-17β-ol-3-one propionate | 4-Androsten-4-chloro-17β-ol-3-one propionate. Uses: Designed for use in research and industrial production. Product Category: Steroidal Compounds. CAS No. 2162-44-9. Molecular formula: C22H31ClO3. Mole weight: 378.93. Purity: 95%+. Product ID: ACM2162449. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Androsten-4-Ol-3,17-Dione Acetate | 4-Androsten-4-Ol-3,17-Dione Acetate. Uses: Designed for use in research and industrial production. Additional or Alternative Names: [(8R,9S,10R,13S,14S)-10,13-dimethyl-3,17-dioxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-4-yl] acetate. Product Category: Steroidal Compounds. CAS No. 61630-32-8. Molecular formula: C21H28O4. Mole weight: 344.45. Purity: 95%+. IUPACName: [(8R,9S,10R,13S,14S)-10,13-dimethyl-3,17-dioxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-4-yl]acetate. Canonical SMILES: CC(=O)OC1=C2CC[C@H]3[C@@H]4CCC(=O)[C@H]4(CC[C@@H]3[C@H]2(CCC1=O)C)C. Density: 1.18g/cm³. Product ID: ACM61630328. Alfa Chemistry ISO 9001:2015 Certified. Categories: 4-Acetoxy-4-androstene-3,17-dione. | |
| 4-Androsten-6α,17β-diol-3-one | 4-Androsten-6α,17β-diol-3-one. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4-ANDROSTEN-6-ALPHA, 17-BETA-DIOL-3-ONE;4-ANDROSTENE-6ALPHA,17BETA-DIOL-3-ONE;6-ALPHA-HYDROXYTESTOSTERONE;6ALPHA,17BETA-DIHYDROXY-4-ANDROSTEN-3-ONE;6A-hydroxytestosterone--dea*schedule iii item;6A-HYDROXYTESTOSTERONE--DEA SCHEDULE III;6,17-Dihydroxy-617b. Product Category: Steroidal Compounds. Appearance: solid. CAS No. 2944-87-8. Molecular formula: C19H28O3. Mole weight: 304.42. Purity: 95%+. IUPACName: (6S,8R,9S,10R,13S,14S,17S)-6,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one. Canonical SMILES: CC12CCC3C(C1CCC2O)CC(C4=CC(=O)CCC34C)O. Density: 1.19g/cm³. Product ID: ACM2944878. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Androsten-6β-ol-3,17-dione | 4-Androsten-6β-ol-3,17-dione. Uses: Designed for use in research and industrial production. Additional or Alternative Names: (6β)-. Product Category: Steroidal Compounds. CAS No. 63-00-3. Molecular formula: C19H26O3. Mole weight: 302.41. Purity: 95%+. IUPACName: (6R,8R,9S,10R,13S,14S)-6-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione. Canonical SMILES: CC12CCC3C(C1CCC2=O)CC(C4=CC(=O)CCC34C)O. Density: 1.19g/cm³. Product ID: ACM63003. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Androsten-7α-ol-3,17-dione | 4-Androsten-7α-ol-3,17-dione. Uses: Designed for use in research and industrial production. Product Category: Steroidal Compounds. CAS No. 62-84-0. Molecular formula: C19H26O3. Mole weight: 302.41. Purity: 95%+. IUPACName: (7R,8R,9S,10R,13S,14S)-7-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione. Canonical SMILES: CC12CCC3C(C1CCC2=O)C(CC4=CC(=O)CCC34C)O. Product ID: ACM62840. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Androsten-7β,17β-diol-3-one | 4-Androsten-7β,17β-diol-3-one. Uses: Designed for use in research and industrial production. Product Category: Steroidal Compounds. CAS No. 969-13-1. Molecular formula: C19H28O3. Mole weight: 304.42. Purity: 95%+. Product ID: ACM969131. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-ANDROSTEN-7β, 17β-DIOL-3-ONE | 4-ANDROSTEN-7β, 17β-DIOL-3-ONE. Group: Biochemicals. Alternative Names: 7β-HYDROXYTESTOSTERONE. CAS No. 969-13-1. US Biological Life Sciences. | Worldwide |
| 4-Androstene-3,17-dione | 4-Androstene-3,17-dione. CAS No. 63-05-8. Product ID: 8-01510. Molecular formula: C19H28O2. Mole weight: 286.41. Purity: ³98%. Reference: Micron , 32, 75, 2001; J. Struct. Biol. , 136, 144, 2001, Methods and Results in Crystallization of Membrane Proteins, S. Iwata, ed., International University Line, La Jolla, 2003. |  |
| 4-Androstene-3,17-dione | 5g Pack Size. Group: Bioactive Small Molecules, Building Blocks, Research Organics & Inorganics. Formula: C19H26O2. CAS No. 63-05-8. Prepack ID 15237310-5g. Molecular Weight 286.41. See USA prepack pricing. |  |
| 4-Anhydro-2-O-(2,4-dimethoxybenzoyl)-3,5-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-4-thio-D-ribitol | 4-Anhydro-2-O-(2,4-dimethoxybenzoyl)-3,5-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-4-thio-D-ribitol is a compound used in the biomedical industry for various applications. It exhibits potential in the treatment of certain diseases such as cancer, inflammation, and metabolic disorders. This product acts as a key ingredient or precursor in the synthesis of drugs targeting specific molecular pathways associated with these conditions. Its unique structural features make it a valuable tool in drug development and biomedical research. CAS No. 291758-12-8. | |
| 4-Anilino-1,1':4',1''-terphenyl | 4-Anilino-1,1':4',1''-terphenyl. Group: Small molecule semiconductor building blockssemiconductor blocks. CAS No. 897671-81-7. Product ID: N-phenyl-4-(4-phenylphenyl)aniline. Molecular formula: 321.4g/mol. Mole weight: C24H19N. C1=CC=C (C=C1)C2=CC=C (C=C2)C3=CC=C (C=C3)NC4=CC=CC=C4. InChI=1S/C24H19N/c1-3-7-19 (8-4-1)20-11-13-21 (14-12-20)22-15-17-24 (18-16-22)25-23-9-5-2-6-10-23/h1-18, 25H. VWXSLLOSYCKNCF-UHFFFAOYSA-N. | |
| 4-Anilino-1-benzylpiperidine | Intermediate in the preparation of Fentanyl derivatives. Group: Biochemicals. Alternative Names: 1-Benzyl-4- (phenylamino) piperidine; 1-Benzyl-4-anilinopiperidine; N-Phenyl-1-(phenylmethyl)-4-piperidinamine; NSC 76613. Grades: Highly Purified. CAS No. 1155-56-2. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| 4-Anilino-4-oxobutanoic acid | 4-Anilino-4-oxobutanoic acid. Group: Biochemicals. Alternative Names: N-Phenyl-succinamic acid; Butanedioic acid anilide; 4-Oxo-4-(phenylamino)-butanoic acid. Grades: Highly Purified. CAS No. 102-14-7. Pack Sizes: 500mg, 1g, 2g, 5g, 10g. Molecular Formula: C10H11NO3. US Biological Life Sciences. | Worldwide |
| 4-Anilinomethylene-pentenedioic Acid-5-methyl Ester-d5 | 4-Anilinomethylene-pentenedioic Acid-5-methyl Ester-d5. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| 4-Anisic Acid | Anisic Acid. CAS No. 100-09-4. Categories: 4-methoxybenzoic acid; p-anisic acid. |  Pennsylvania PA |
| 4-ANISIDINE-2-SS-HYDROXYETHYL SULFONE SULFATE ESTER | 4-ANISIDINE-2-SS-HYDROXYETHYL SULFONE SULFATE ESTER. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 4-ANISIDINE-2-SS-HYDROXYETHYL SULFONE SULFATE ESTER;4-Anisidine-2--hydroxyethyl sulfone sulfate ester;4-ANISIDINE-2-B-HYDROXYETHYLSULFONE SULFATE;2-[(5-Amino-2-methoxyphenyl)-sulfonyl]-ethyl hydrogen sulfate;4-ANISIDINE-2-B-HYDROXYETHYL SULFONE SULFATE E. Product Category: Heterocyclic Organic Compound. CAS No. 52532-52-2. Molecular formula: C9H13NO7S2. Mole weight: 311.334. Purity: 0.96. IUPACName: 2-(5-amino-2-methoxyphenyl)sulfonylethylhydrogensulfate. Canonical SMILES: COC1=C(C=C(C=C1)N)S(=O)(=O)CCOS(=O)(=O)O. Product ID: ACM52532522. Alfa Chemistry ISO 9001:2015 Certified. | |
| 4-Anisyl chlorodiphenyl methane | 4-Anisyl chlorodiphenyl methane . Group: Biochemicals. Alternative Names: (Chloro (-methoxyphenyl) methylene) dibenzene; MMT-Cl; 4-Methoxytri phenylchloromethane ; p-Monomethoxytrityl chloride. Grades: Highly Purified. CAS No. 14470-28-1. Pack Sizes: 25g, 50g, 100g, 250g, 500g. Molecular Formula: C20H17ClO. US Biological Life Sciences. | Worldwide |
| 4'-Apo-b-carotenal | 4'-Apo-b-carotenal. Group: Biochemicals. Alternative Names: 4'-Apo-b-caroten-4'-al. Grades: Highly Purified. Pack Sizes: 1mg, 2mg, 5mg. US Biological Life Sciences. | Worldwide |
| 4arm-PEG10K | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K 2arm-OH 2arm-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG 2arm-OH 2arm-COOH. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K 2arm-OH 2arm-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG 2arm-OH 2arm-NH2. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K 3arm-OH 1arm-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG 3arm-OH 1arm-COOH. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K 3arm-OH 1arm-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG 3arm-OH 1arm-NH2. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: 3d printing materials poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Acrylate, 4arm-PEG-ACLT. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-COOH, 4arm-PEG-Carboxyl. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Glutaric Acid | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Glutaric Acid. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Isocyanate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Maleimide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-MAL, 4arm-PEG-Maleimide. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-NH2, 4arm-PEG-NH2. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-SH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-SH. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Ester, 4arm-PEG-SCM. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Succinimidyl Carboxymethyl Glutaramide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Glutaramide. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Succinimidyl Glutarate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Glutarate. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Succinimidyl Succinate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Succinate. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Vinylsulfone | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-VS, 4arm-PEG-Vinylsulfone. Molecular formula: average Mn 10000. | |
| 4arm-PEG20K 2arm-OH, 2arm-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 20000. | |
| 4arm-PEG20K 3arm-OH, 1arm-NH2 | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-Acrylate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: 3d printing materials poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Acrylate, 4arm-PEG-ACLT. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-COOH | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-COOH, 4arm-PEG-Carboxyl. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-Isocyanate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Isocyanate. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-Maleimide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-MAL, 4arm-PEG-Maleimide. Molecular formula: average Mn 20000. | |
Our database is helping our users find suppliers everyday.
